Dementia remains one of the leading causes of morbidity and mortality in older adults.
Alzheimer's disease (AD) is the most common type of dementia, affecting over 55 million …

Pre-clinical research in aging is hampered by the scarcity of studies modeling its
heterogeneity and complexity forged by pathophysiological conditions throughout the life …

Alzheimer's disease (AD) is a neurodegenerative disorder that is characterized by
progressive impairment in cognition and memory. AD is accompanied by several …

Depression is a multifactorial disease with unknown etiology affecting globally. It's the
second most significant reason for infirmity in 2020, affecting about 50 million people …

Depression is among the most frequent psychiatric comorbid conditions in Alzheimer
disease (AD). However, pharmacotherapy for depressive disorders in AD is still a big …

Over the past few decades, clinicians and experts applied kinds of therapies for patients with
malignant gliomas such as chemotherapy, radiation or surgical extraction. However, they …

The prevalence of Alzheimer's disorder (AD) is increasing worldwide, and the co-morbid
anxiety is an important, albeit often neglected problem, which might appear early during …

Alzheimer's disease (AD) is a progressive and degenerative disorder accompanied by
emotional disturbance, especially anxiety and depression. More and more evidence shows …

According to previous studies, the median raphe region (MRR) is known to contribute
significantly to social behavior. Besides serotonin, there have also been reports of a small …

Generalized linear mixed models (GLMMs) are a cornerstone data analysis strategy in
behavioral research because of their robustness in handling non-normally distributed …